Kat Petrilli

1.0k total citations · 1 hit paper
24 papers, 587 citations indexed

About

Kat Petrilli is a scholar working on Pharmacology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Kat Petrilli has authored 24 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 6 papers in Epidemiology. Recurrent topics in Kat Petrilli's work include Cannabis and Cannabinoid Research (22 papers), Substance Abuse Treatment and Outcomes (6 papers) and Bipolar Disorder and Treatment (5 papers). Kat Petrilli is often cited by papers focused on Cannabis and Cannabinoid Research (22 papers), Substance Abuse Treatment and Outcomes (6 papers) and Bipolar Disorder and Treatment (5 papers). Kat Petrilli collaborates with scholars based in United Kingdom, United States and Australia. Kat Petrilli's co-authors include Tom P. Freeman, Rachel Lees, Chandni Hindocha, Claire Mokrysz, Valerie H. Curran, Matthew B. Wall, Michael Bloomfield, Lindsey A. Hines, Sally Adams and Abigail M. Freeman and has published in prestigious journals such as Biological Psychiatry, Neuroscience & Biobehavioral Reviews and Pharmacology & Therapeutics.

In The Last Decade

Kat Petrilli

22 papers receiving 580 citations

Hit Papers

Association of cannabis potency with mental ill health an... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kat Petrilli United Kingdom 10 490 149 117 107 102 24 587
Rachel Lees United Kingdom 11 541 1.1× 190 1.3× 122 1.0× 130 1.2× 96 0.9× 27 670
Jack Wilson Australia 10 468 1.0× 96 0.6× 63 0.5× 101 0.9× 158 1.5× 23 657
Mark Montebello Australia 10 386 0.8× 175 1.2× 64 0.5× 114 1.1× 163 1.6× 34 574
Ravi K. Das United Kingdom 6 426 0.9× 124 0.8× 61 0.5× 65 0.6× 123 1.2× 8 469
Skyler G. Shollenbarger United States 9 343 0.7× 113 0.8× 147 1.3× 105 1.0× 119 1.2× 14 534
Nicolas J. Schlienz United States 17 594 1.2× 170 1.1× 129 1.1× 76 0.7× 192 1.9× 34 873
Arianna Marconi Italy 4 424 0.9× 105 0.7× 71 0.6× 264 2.5× 97 1.0× 5 614
Willemijn A. van Gastel Netherlands 11 358 0.7× 113 0.8× 75 0.6× 205 1.9× 55 0.5× 15 519
Sophie L. YorkWilliams United States 12 264 0.5× 83 0.6× 104 0.9× 56 0.5× 100 1.0× 17 453
Mercè Balcells‐Oliveró Spain 13 309 0.6× 116 0.8× 62 0.5× 48 0.4× 170 1.7× 44 551

Countries citing papers authored by Kat Petrilli

Since Specialization
Citations

This map shows the geographic impact of Kat Petrilli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kat Petrilli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kat Petrilli more than expected).

Fields of papers citing papers by Kat Petrilli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kat Petrilli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kat Petrilli. The network helps show where Kat Petrilli may publish in the future.

Co-authorship network of co-authors of Kat Petrilli

This figure shows the co-authorship network connecting the top 25 collaborators of Kat Petrilli. A scholar is included among the top collaborators of Kat Petrilli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kat Petrilli. Kat Petrilli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Donald R., Claire Mokrysz, Rachel Lees, et al.. (2025). Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents. Communications Medicine. 5(1). 300–300.
2.
Freeman, Tom P., Daniel L. Hall, Claire Mokrysz, et al.. (2024). The effects of acute cannabis with and without cannabidiol on neural reward anticipation in adults and adolescents. Neuroscience Applied. 3. 103989–103989. 2 indexed citations
3.
Freeman, Tom P., Claire Mokrysz, Anna Borissova, et al.. (2024). Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks. Neuropsychopharmacology. 49(10). 1640–1651. 10 indexed citations
4.
Lees, Rachel, Will Lawn, Kat Petrilli, et al.. (2024). Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European Archives of Psychiatry and Clinical Neuroscience. 275(2). 397–406. 6 indexed citations
6.
Lawn, Will, Claire Mokrysz, Tom P. Freeman, et al.. (2023). Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults. Journal of Psychopharmacology. 37(9). 904–919. 6 indexed citations
7.
Lawn, Will, Claire Mokrysz, Anna Borissova, et al.. (2023). The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment. Addiction. 118(7). 1282–1294. 24 indexed citations
8.
Petrilli, Kat, Lindsey A. Hines, Sally Adams, et al.. (2023). High potency cannabis use, mental health symptoms and cannabis dependence: Triangulating the evidence. Addictive Behaviors. 144. 107740–107740. 15 indexed citations
9.
10.
Freeman, Tom P., Daniel L. Hall, Claire Mokrysz, et al.. (2022). The Effects of Acute Cannabis With and Without Cannabidiol on Neural Reward Anticipation in Adults and Adolescents. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 8(2). 219–229. 7 indexed citations
11.
Petrilli, Kat, et al.. (2022). Association of cannabis potency with mental ill health and addiction: a systematic review. The Lancet Psychiatry. 9(9). 736–750. 110 indexed citations breakdown →
12.
Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2022). The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls. Psychopharmacology. 239(5). 1629–1641. 9 indexed citations
13.
Mokrysz, Claire, Tom P. Freeman, Matthew B. Wall, et al.. (2022). Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls. Neuropsychopharmacology. 47(11). 1976–1983. 15 indexed citations
14.
Borissova, Anna, Elizabeth R. Aston, Rachel Lees, et al.. (2022). Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward?. Drug and Alcohol Dependence. 238. 109531–109531. 6 indexed citations
15.
Mokrysz, Claire, Tom P. Freeman, Vincent Valton, et al.. (2022). Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls. The International Journal of Neuropsychopharmacology. 26(1). 9–19. 12 indexed citations
16.
Bloomfield, Michael, Kat Petrilli, Rachel Lees, et al.. (2021). The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study. Biological Psychiatry Cognitive Neuroscience and Neuroimaging. 6(6). 660–667. 3 indexed citations
17.
Lawn, Will, Claire Mokrysz, Daniel L. Hall, et al.. (2021). Do adolescents and adults differ in the acute subjective, psychotomimetic, and memory-impairing effects of cannabis?. OSF Preprints (OSF Preprints). 1 indexed citations
18.
Lawn, Will, Claire Mokrysz, Rachel Lees, et al.. (2021). P.0320 Depression, anxiety, psychotic-like symptoms and addiction in adolescents and adults who do and do not use cannabis. European Neuropsychopharmacology. 53. S232–S233. 1 indexed citations
19.
Freeman, Abigail M., Kat Petrilli, Rachel Lees, et al.. (2019). How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neuroscience & Biobehavioral Reviews. 107. 696–712. 153 indexed citations
20.
Bloomfield, Michael, Chandni Hindocha, Sebastian F Green, et al.. (2018). The neuropsychopharmacology of cannabis: A review of human imaging studies. Pharmacology & Therapeutics. 195. 132–161. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026